354 related articles for article (PubMed ID: 18625450)
1. Inhibition and modulation of gamma-secretase for Alzheimer's disease.
Wolfe MS
Neurotherapeutics; 2008 Jul; 5(3):391-8. PubMed ID: 18625450
[TBL] [Abstract][Full Text] [Related]
2. Gamma-secretase inhibition and modulation for Alzheimer's disease.
Wolfe MS
Curr Alzheimer Res; 2008 Apr; 5(2):158-64. PubMed ID: 18393800
[TBL] [Abstract][Full Text] [Related]
3. Interacting with γ-secretase for treating Alzheimer's disease: from inhibition to modulation.
Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Logroscino G; Santamato A; Greco A; Seripa D; Pilotto A
Curr Med Chem; 2011; 18(35):5430-47. PubMed ID: 22087836
[TBL] [Abstract][Full Text] [Related]
4. Selective amyloid-beta lowering agents.
Wolfe MS
BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S4. PubMed ID: 19090992
[TBL] [Abstract][Full Text] [Related]
5. gamma-Secretase modulators.
Wolfe MS
Curr Alzheimer Res; 2007 Dec; 4(5):571-3. PubMed ID: 18220525
[TBL] [Abstract][Full Text] [Related]
6. γ-Secretase in Alzheimer's disease.
Hur JY
Exp Mol Med; 2022 Apr; 54(4):433-446. PubMed ID: 35396575
[TBL] [Abstract][Full Text] [Related]
7. gamma-Secretase as a therapeutic target in Alzheimer's disease.
Guardia-Laguarta C; Pera M; Lleó A
Curr Drug Targets; 2010 Apr; 11(4):506-17. PubMed ID: 20015011
[TBL] [Abstract][Full Text] [Related]
8. γ-Secretase as a target for Alzheimer's disease.
Wolfe MS
Adv Pharmacol; 2012; 64():127-53. PubMed ID: 22840746
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of gamma-secretase as a therapeutic intervention for Alzheimer's disease: prospects, limitations and strategies.
Evin G; Sernee MF; Masters CL
CNS Drugs; 2006; 20(5):351-72. PubMed ID: 16696577
[TBL] [Abstract][Full Text] [Related]
10. Discovery of notch-sparing gamma-secretase inhibitors.
Augelli-Szafran CE; Wei HX; Lu D; Zhang J; Gu Y; Yang T; Osenkowski P; Ye W; Wolfe MS
Curr Alzheimer Res; 2010 May; 7(3):207-9. PubMed ID: 20088802
[TBL] [Abstract][Full Text] [Related]
11. Probing Mechanisms and Therapeutic Potential of γ-Secretase in Alzheimer's Disease.
Wolfe MS
Molecules; 2021 Jan; 26(2):. PubMed ID: 33450968
[TBL] [Abstract][Full Text] [Related]
12. Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease.
D'Onofrio G; Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Paroni G; Cascavilla L; Seripa D; Pilotto A
Expert Opin Drug Discov; 2012 Jan; 7(1):19-37. PubMed ID: 22468891
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of gamma-secretase inhibitors and modulators.
Imbimbo BP
Curr Top Med Chem; 2008; 8(1):54-61. PubMed ID: 18220933
[TBL] [Abstract][Full Text] [Related]
14. [Alzheimer's disease treatment by inhibition/modulation of the gamma-secretase activity].
Tomita T
Rinsho Shinkeigaku; 2009 Nov; 49(11):845-7. PubMed ID: 20030227
[TBL] [Abstract][Full Text] [Related]
15. γ-secretase inhibitors and modulators for the treatment of Alzheimer's disease: disappointments and hopes.
Imbimbo BP; Giardina GA
Curr Top Med Chem; 2011; 11(12):1555-70. PubMed ID: 21510832
[TBL] [Abstract][Full Text] [Related]
16. Quantification of gamma-secretase modulation differentiates inhibitor compound selectivity between two substrates Notch and amyloid precursor protein.
Yang T; Arslanova D; Gu Y; Augelli-Szafran C; Xia W
Mol Brain; 2008 Nov; 1():15. PubMed ID: 18983676
[TBL] [Abstract][Full Text] [Related]
17. Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.
Martone RL; Zhou H; Atchison K; Comery T; Xu JZ; Huang X; Gong X; Jin M; Kreft A; Harrison B; Mayer SC; Aschmies S; Gonzales C; Zaleska MM; Riddell DR; Wagner E; Lu P; Sun SC; Sonnenberg-Reines J; Oganesian A; Adkins K; Leach MW; Clarke DW; Huryn D; Abou-Gharbia M; Magolda R; Bard J; Frick G; Raje S; Forlow SB; Balliet C; Burczynski ME; Reinhart PH; Wan HI; Pangalos MN; Jacobsen JS
J Pharmacol Exp Ther; 2009 Nov; 331(2):598-608. PubMed ID: 19671883
[TBL] [Abstract][Full Text] [Related]
18. At the frontline of Alzheimer's disease treatment: gamma-secretase inhibitor/modulator mechanism.
Tomita T
Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):295-300. PubMed ID: 18038124
[TBL] [Abstract][Full Text] [Related]
19. Development and mechanism of γ-secretase modulators for Alzheimer's disease.
Crump CJ; Johnson DS; Li YM
Biochemistry; 2013 May; 52(19):3197-216. PubMed ID: 23614767
[TBL] [Abstract][Full Text] [Related]
20. [Development of Alzheimer's disease treatment based on the molecular mechanism of γ-secretase activity].
Tomita T
Rinsho Shinkeigaku; 2012; 52(11):1165-7. PubMed ID: 23196551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]